Drug Profile
KGYY 15
Alternative Names: KGYY15Latest Information Update: 06 Sep 2023
Price :
$50
*
At a glance
- Originator Op-T-Mune
- Class Peptides
- Mechanism of Action CD40 ligand inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Multiple sclerosis
Most Recent Events
- 06 Sep 2023 Discontinued - Preclinical for Multiple sclerosis in USA (Parenteral)
- 28 Jan 2019 No recent reports of development identified for preclinical development in Multiple-sclerosis in USA (Parenteral)